Sunday, February 23, 2020

Sunday, February 23, 2020

U.S. FOOD AND DRUG ADMINISTRATION: Azithromycin (Azasite) Ophthalmic Solution 1%

U.S. Food and Drug Administration recently issued the following announcement.

Azithromycin (Azasite) Ophthalmic Solution 1%

Status: Currently in Shortage

»Date first posted: 05/09/2018

»Therapeutic Categories: Ophthalmology

Akorn Pharmaceuticals (Revised 10/04/2018)

Company Contact Information:


Presentation: Azasite (Azithromycin Ophthalmic Solution) 1% 2.5 mL in 5 mL bottle (NDC 17478-307-03)

Availability and Estimated Shortage Duration: Product is currently available.

Related Information: Estimated recovery 4Q2018

Shortage Reason (per FDASIA): Delay in shipping of the drug

Original source can be found here.

Organizations in this Story

U.S. Food and Drug Administration

More News

FDA Reporter